Multi-gene assays: effect on chemotherapy use, toxicity and cost in estrogen receptor-positive early stage breast cancer.

CONCLUSION: MGAs differ in chemotherapy use and related outcomes for women with estrogen receptor-positive early breast cancer. PMID: 30663337 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research